Skip to main content
. 2023 Jan 11;20(2):1361. doi: 10.3390/ijerph20021361

Table 2.

Summary of the psychometric assessment results (questionnaires).

Questionnaire Dimensions (Score Min–Max) Group Baseline Post Diff Base-Post
CFQ 11 Physical fatigue (0–21) ††† G-Nor 6.8 ± 1.4 7.2 ± 1.1 +0.4
    G-Con 18.4 ± 2.4 ∆∆∆ 17.8 ± 2.2 ∆∆∆ −0.6
    G-Int 17.8 ± 2.2 ∆∆∆ 4.8 ± 4.1 °°°*** −13
  Mental fatigue (0–12) ††† G-Nor 4 ± 0.4 4.3 ± 0.7 +0.3
    G-Con 10.9 ± 1.5 ∆∆∆ 10.6 ± 1.7 ∆∆∆ −0.3
    G-Int 10.4 ± 1.6 ∆∆∆ 2.7 ± 3.1 °°°*** −7.7
HADS Anxiety (0–21) G-Nor 4.0 ± 2.4 3.3 ± 1.2 −0.7
    G-Con 12.9 ± 3.2 ∆∆∆ 11.4 ± 3.5 ∆∆∆ −1.5
    G-Int 10.8 ± 3.5 ∆∆∆ 7.2 ± 3.0 ∆∆°°*** −3.6
  Depression (0–21) ††† G-Nor 2.0 ± 1.3 2.7 ± 1.6 +0.7
    G-Con 12.5 ± 4.3 ∆∆∆ 11.9 ± 4.6 ∆∆∆ −0.6
    G-Int 11.9 ± 2.7 ∆∆∆ 6.7 ± 3.6 °°°*** −5.2
mMRC Dyspnea (0–4) G-Nor 0.2 ± 0.4 0.2 ± 0.4 0
    G-Con 1.4 ± 0.7 ∆∆∆ 1.2 ± 0.7 ∆∆∆ −0.2
    G-Int 1.5 ± 0.9 ∆∆∆ 1.1 ± 0.7∆∆* −0.4
VAS Pain Muscle and Joint (0–10) G-Nor 1.7 ± 1.5 1.0 ± 1.1 −0.7
    G-Con 7.1 ± 1.4 ∆∆∆ 6.8 ± 1.4 ∆∆∆ −0.3
    G-Int 6.4 ± 1.6 ∆∆∆ 4.6 ± 2.2 ∆∆∆°°°** −1.8
  Headaches (0–10) †† G-Nor 0.7 ± 1.0 0.3 ± 0.7 −0.4
    G-Con 7.2 ± 1.7 ∆∆∆ 6.5 ± 2.2 ∆∆∆ −0.7
    G-Int 5.3 ± 2.6 ∆∆∆ 2.8 ± 1.7 ∆∆°°°*** −2.5
SSQ Sleep quality (0–30) G-Nor 20.5 ± 3.1 22.1 ± 2.9 +1.6
    G-Con 14.0 ± 3.8 ∆∆∆ 16.0 ± 3.1 ∆∆∆ +2.0
    G-Int 15.1 ± 3.8 ∆∆∆ 18.5 ± 4.5 * +3.4
POMS Tension-Anxiety (0–24) ††† G-Nor 4.8 ± 1.8 3.9 ± 2.6 −0.9
    G-Con 15.6 ± 4.1 ∆∆∆ 15.6 ± 6.2 ∆∆∆ 0
    G-Int 13.2 ± 5.2 ∆∆∆ 7.5 ± 4.8 °°°*** −5.7
  Anger-Hostility (0–24) ††† G-Nor 2.8 ± 1.7 2.0 ± 1.7 −0.8
    G-Con 11.9 ± 3.4 ∆∆∆ 10.8 ± 6.1 ∆∆∆ −1.1
    G-Int 9.9 ± 5.9 ∆∆∆ 4.5 ± 4.2 °°°*** −5.4
  Fatigue-Inertia (0–20) ††† G-Nor 4.9 ± 3.5 3.3 ± 2.3 −1.6
    G-Con 16.4 ± 3.3 ∆∆∆ 16.2 ± 3.4 ∆∆∆ −0.2
    G-Int 14.6 ± 2.8 ∆∆∆ 9.1 ± 3.6 ∆∆∆°°°*** −5.5
  Depression-Dejection (0–28) †† G-Nor 1.1 ± 1.5 0.5 ± 0.5 −0.6
    G-Con 14.0 ± 7.1 ∆∆∆ 12.6 ± 8.2 ∆∆∆ −1.4
    G-Int 11.0 ± 6.4 ∆∆∆ 5.8 ± 4.8 °°*** −5.2
  Esteem-related affect (0–24) ††† G-Nor 18.4 ± 1.8 16.9 ± 2.8 −1.5
    G-Con 9.0 ± 3.3 ∆∆∆ 9.5 ± 3.6 ∆∆∆ +0.5
    G-Int 11.1 ± 3.4 ∆∆∆ 13.9 ± 3.2 °°** +2.8
  Vigor-Activity (0–20) G-Nor 14.5 ± 3.7 13.9 ± 3.5 −0.6
    G-Con 4.3 ± 3.3 ∆∆∆ 4.2 ± 2.3 ∆∆∆ −0.1
    G-Int 5.8 ± 1.8 ∆∆∆ 7.1 ± 4.1 ∆∆∆ +1.3
  Confusion-Bewilderment (0–24) ††† G-Nor 4.9 ± 2.6 3.1 ± 2.2 −1.8
    G-Con 14.4 ± 3.1 ∆∆∆ 14.2 ± 4.0 ∆∆∆ −0.2
    G-Int 13.7 ± 3.4 ∆∆∆ 8.4 ± 3.2 ∆∆∆°°°*** −5.3
  Total Mood Disturbance (−44–76) ††† G-Nor −14.2 ± 11.3 −17.5 ± 14.0 −3.3
    G-Con 58.9 ± 22.0 ∆∆∆ 55.6 ± 30.3 ∆∆∆ −3.3
    G-Int 45.5 ± 22.8 ∆∆∆ 14.2 ± 21.7 ∆∆°°°*** −31.3

Notes: CFQ 11: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; mMRC: Modified medical research council dyspnea scale; VAS Pain: Visual Analog Scale for pain; SSQ: Spiegel Sleep Questionnaire; POMS: Profile Of Mood States. Significant time–group interaction (p < 0.05) †† Significant time–group interaction (p < 0.01) ††† Significant time–group interaction (p < 0.001); Significantly different from G-Nor (p < 0.05) ∆∆ Significantly different from G-Nor (p < 0.01) ∆∆∆ Significantly different from G-Nor (p < 0.001); °° Significantly different from G-Con (p < 0.01) °°° Significantly different from G-Con (p < 0.001); * Significantly different from Baseline (p < 0.05) ** Significantly different from Baseline (p < 0.01) *** Significantly different from Baseline (p < 0.001).